|
|
|
|
| Advertisement |
Read this Front & Center article to see how your Hub can be a Secret Weapon to improve Outcomes.  Learn more
|
|
| Advertisement |
Podcast: Assuring Trust in the Digital Space
Pharm Exec talks to Mollie Shields-Uehling, a leading advocate for high-assurance identity trust for cyber-transactions in the biopharmaceutical industry. Listen to the podcast for a timely, 15-minute discussion covering topics like cyber/technical security; eHealth regulatory compliance; work flow automation, the benefits of eSignature programs, and collaboration around key aspects of drug development like the administration of clinical trials and research partnering.  Click here to listen >>
|
|
|
|
| Advertisement |
How the Life Sciences Cloud Coalition Is Driving Greater Innovation and Collaboration for Sponsors
Live Webinar: Tuesday, November 15 at 11:00am EST
 Register now
|
|
| Interview |
 |
|
Flipping the Generics Map: Apotex's Jeremy Desai |
Jeremy Desai, CEO of Apotex, Canada's largest producer of generic drugs, discusses the local impact of mounting pricing pressure—and how smaller and independent companies can survive in an era of consolidation and growing competition
… /Read more/ |
|
|
| Advertisement |
Achieving Success in the Biosimilar Market
On Demand
 Learn more
|
|
|
ADVERTISEMENT
|
| Advertisement |
Supporting internal and external decision-making through effective MSL activities
On Demand
 Learn more
|
|
| Industry update |
| //Loxo Oncology (Stamford, CT) announced the appointment of Steve D. Harr, M.D., to its Board of Directors. //Galena Biopharma (San Ramon, CA) appointed Stephen F. Ghiglieri as Executive Vice President and Chief Financial Officer.//Pernix Therapeutics Holdings (Morristown, NJ) appointed Graham G. Miao, Ph.D. and Dennis H. Langer, M.D., J.D. to its Board of Directors. // |
|
|
